Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (151-160 of 297) with videos related to

Pageof 30
Sort By:
Journal of Psychiatric Research|April 3, 2012
The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patientsHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
International Journal of Molecular Sciences|March 9, 2017
Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute SchizophreniaHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
International Journal of Psychiatry in Clinical Practice|June 20, 2014
Fluctuating plasma levels of the active moiety of risperidone is related to occurrence of extrapyramidal symptomsReiji Yoshimura, Nobuhisa Ueda, Atsuko Ikenouch-Sugita, et al.
Biochemical Pharmacology|June 6, 2003
Inhibition of the norepinephrine transporter function in cultured bovine adrenal medullary cells by bisphenol AYumiko Toyohira, Kensuke Utsunomiya, Susumu Ueno, et al.
Neuropsychiatric Disease and Treatment|November 6, 2020
Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry StudyNaomichi Okamoto, Keita Watanabe, LeHoa Ngyuyen, et al.
International Journal of Molecular Sciences|April 30, 2020
Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive DisorderAsuka Katsuki, Keita Watanabe, LeHoa Nguyen, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|August 27, 2009
Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective studyHikaru Hori, Nobuhisa Ueda, Reiji Yoshimura, et al.
Frontiers in Psychiatry|April 10, 2023
Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorderEnkhmurun Chibaatar, Keita Watanabe, Naomichi Okamoto, et al.
Preventive Medicine Reports|November 1, 2021
Association between loneliness and psychological distress: A cross-sectional study among Japanese workers during the COVID-19 pandemicYusuke Konno, Masako Nagata, Ayako Hino, et al.
Human Psychopharmacology|March 3, 2010
Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot studyYuichiro Nakano, Reiji Yoshimura, Hideki Nakano, et al.
Pageof 30

Showing results (151-160 of 297) with videos related to

Sort By:
Pageof 30
Journal of Psychiatric Research|April 3, 2012
The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patientsHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
International Journal of Molecular Sciences|March 9, 2017
Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute SchizophreniaHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
International Journal of Psychiatry in Clinical Practice|June 20, 2014
Fluctuating plasma levels of the active moiety of risperidone is related to occurrence of extrapyramidal symptomsReiji Yoshimura, Nobuhisa Ueda, Atsuko Ikenouch-Sugita, et al.
Biochemical Pharmacology|June 6, 2003
Inhibition of the norepinephrine transporter function in cultured bovine adrenal medullary cells by bisphenol AYumiko Toyohira, Kensuke Utsunomiya, Susumu Ueno, et al.
Neuropsychiatric Disease and Treatment|November 6, 2020
Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry StudyNaomichi Okamoto, Keita Watanabe, LeHoa Ngyuyen, et al.
International Journal of Molecular Sciences|April 30, 2020
Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive DisorderAsuka Katsuki, Keita Watanabe, LeHoa Nguyen, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|August 27, 2009
Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective studyHikaru Hori, Nobuhisa Ueda, Reiji Yoshimura, et al.
Frontiers in Psychiatry|April 10, 2023
Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorderEnkhmurun Chibaatar, Keita Watanabe, Naomichi Okamoto, et al.
Preventive Medicine Reports|November 1, 2021
Association between loneliness and psychological distress: A cross-sectional study among Japanese workers during the COVID-19 pandemicYusuke Konno, Masako Nagata, Ayako Hino, et al.
Human Psychopharmacology|March 3, 2010
Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot studyYuichiro Nakano, Reiji Yoshimura, Hideki Nakano, et al.
Pageof 30